V Trademark

Trademark Overview

On Monday, November 27, 2023, a trademark application was filed for V with the United States Patent and Trademark Office. The USPTO has given the V trademark a serial number of 79388199. The federal status of this trademark filing is REGISTERED as of Tuesday, October 22, 2024. This trademark is owned by Astellas Pharma Inc.. The V trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical product for the treatment of cancer
v

General Information

Serial Number79388199
Word MarkV
Filing DateMonday, November 27, 2023
Status700 - REGISTERED
Status DateTuesday, October 22, 2024
Registration Number7540115
Registration DateTuesday, October 22, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements

Description of MarkThe mark consists of the stylized letter V made up of two quadrilaterals, superimposed on the left quadrilateral is a design of a triangle and between the two quadrilaterals is a design of an upside down triangle with a curved side.
Goods and ServicesPharmaceutical product for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstellas Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP
Party NameAstellas Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events

Event DateEvent Description
Thursday, February 1, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 2, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 6, 2024APPLICATION FILING RECEIPT MAILED
Friday, June 21, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 21, 2024REFUSAL PROCESSED BY MPU
Monday, July 1, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Thursday, May 23, 2024NON-FINAL ACTION WRITTEN
Friday, June 7, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, June 7, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 15, 2024REFUSAL PROCESSED BY IB
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, January 22, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, March 29, 2025FINAL DISPOSITION NOTICE SENT TO IB
Monday, April 14, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, April 14, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 29, 2025FINAL DISPOSITION PROCESSED
Monday, April 14, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 14, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 14, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, April 19, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, July 1, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, July 18, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Related Keywords

cancer treatment product pharmaceutical